367 related articles for article (PubMed ID: 17917875)
21. Effect of serum and CTL on focal growth of human cytomegalovirus.
Sinzger C; Mangin M; Weinstock C; Topp MS; Hebart H; Einsele H; Jahn G
J Clin Virol; 2007 Feb; 38(2):112-9. PubMed ID: 17204454
[TBL] [Abstract][Full Text] [Related]
22. Cytomegalovirus-specific CD4 T-cell and glycoprotein B specific antibody response in recipients of allogenic stem cell transplantation.
Ludwig B; Kraus FB; Kipp M; Preiser W; Schwerdtfeger R; Doerr HW; Buxbaum S
J Clin Virol; 2006 Feb; 35(2):160-6. PubMed ID: 16112610
[TBL] [Abstract][Full Text] [Related]
23. Human cytomegalovirus-specific cytotoxic T lymphocytes: requirements for in vitro generation and specificity.
Borysiewicz LK; Morris S; Page JD; Sissons JG
Eur J Immunol; 1983 Oct; 13(10):804-9. PubMed ID: 6196203
[TBL] [Abstract][Full Text] [Related]
24. Cellular immunotherapy for cytomegalovirus and HIV-1 infection.
Van den Bosch GA; Ponsaerts P; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
J Immunother; 2006; 29(2):107-21. PubMed ID: 16531812
[TBL] [Abstract][Full Text] [Related]
25. Rapid generation of CMV pp65-specific T cells for immunotherapy.
Bao L; Sun Q; Lucas KG
J Immunother; 2007; 30(5):557-61. PubMed ID: 17589296
[TBL] [Abstract][Full Text] [Related]
26. Induction of immunity against human cytomegalovirus.
Bennekov T; Spector D; Langhoff E
Mt Sinai J Med; 2004 Mar; 71(2):86-93. PubMed ID: 15029400
[TBL] [Abstract][Full Text] [Related]
27. Flow cytometric analysis of virus-specific T lymphocytes: practicability of detection of HCMV-specific T lymphocytes in whole blood in patients after stem cell transplantation.
Buxbaum S; Kraus FB; Hahn A; Beck O; Kabartas B; Doerr HW; Ludwig B
J Immunol Methods; 2006 Apr; 311(1-2):164-73. PubMed ID: 16530782
[TBL] [Abstract][Full Text] [Related]
28. Adoptive T cell immunotherapy for cytomegalovirus.
Peggs KS
Expert Opin Biol Ther; 2009 Jun; 9(6):725-36. PubMed ID: 19456207
[TBL] [Abstract][Full Text] [Related]
29. Human cytomegalovirus-specific CD4+ and CD8+ T cell responses in primary infection of the immunocompetent and the immunocompromised host.
Lilleri D; Zelini P; Fornara C; Comolli G; Revello MG; Gerna G
Clin Immunol; 2009 Jun; 131(3):395-403. PubMed ID: 19268633
[TBL] [Abstract][Full Text] [Related]
30. CMV-specific T cell therapy.
Einsele H; Kapp M; Grigoleit GU
Blood Cells Mol Dis; 2008; 40(1):71-5. PubMed ID: 17851094
[TBL] [Abstract][Full Text] [Related]
31. Detailed analysis of IFNg response upon activation permits efficient isolation of cytomegalovirus-specific CD8+ T cells for adoptive immunotherapy.
Zandvliet ML; Falkenburg JH; Jedema I; Willemze R; Guchelaar HJ; Meij P
J Immunother; 2009 Jun; 32(5):513-23. PubMed ID: 19609244
[TBL] [Abstract][Full Text] [Related]
32. Human cytomegalovirus-specific T cell reconstitution in young patients receiving T cell-depleted, allogeneic hematopoietic stem cell transplantation.
Lilleri D; Gerna G; Fornara C; Chiesa A; Comolli G; Zecca M; Locatelli F
J Infect Dis; 2009 Mar; 199(6):829-36. PubMed ID: 19239337
[TBL] [Abstract][Full Text] [Related]
33. Elevated granzyme M-expressing lymphocytes during cytomegalovirus latency and reactivation after allogeneic stem cell transplantation.
Bovenschen N; Spijkers SN; Wensink AC; Schellens IM; van Domselaar R; van Baarle D
Clin Immunol; 2014 Jan; 150(1):1-11. PubMed ID: 24316590
[TBL] [Abstract][Full Text] [Related]
34. Human cytomegalovirus specific CD8(+) T lymphocytes display interferon-gamma secretion impairment in kidney transplant recipients with pp65 antigenemia.
Yang R; Xia T; Xu G; Li Z; Ying Z; Xu X
Transplant Proc; 2008 Dec; 40(10):3500-4. PubMed ID: 19100424
[TBL] [Abstract][Full Text] [Related]
35. Adoptive immunotherapy for cytomegalovirus (CMV) disease in immunocompromised patients.
Lim JB; Kwon OH; Kim HS; Kim HO; Choi JR; Provenzano M; Stroncek D
Yonsei Med J; 2004 Jun; 45 Suppl():18-22. PubMed ID: 15250045
[TBL] [Abstract][Full Text] [Related]
36. Cytomegalovirus infection in immunocompetent and immunocompromised individuals--a review.
Vancíková Z; Dvorák P
Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):179-87. PubMed ID: 12476798
[TBL] [Abstract][Full Text] [Related]
37. Human cytomegalovirus targets different subsets of antigen-presenting cells with pathological consequences for host immunity: implications for immunosuppression, chronic inflammation and autoimmunity.
Varani S; Frascaroli G; Landini MP; Söderberg-Nauclér C
Rev Med Virol; 2009 May; 19(3):131-45. PubMed ID: 19367559
[TBL] [Abstract][Full Text] [Related]
38. Rebuilding human leukocyte antigen class II-restricted minor histocompatibility antigen specificity in recall antigen-specific T cells by adoptive T cell receptor transfer: implications for adoptive immunotherapy.
Spaapen R; van den Oudenalder K; Ivanov R; Bloem A; Lokhorst H; Mutis T
Clin Cancer Res; 2007 Jul; 13(13):4009-15. PubMed ID: 17606735
[TBL] [Abstract][Full Text] [Related]
39. Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus.
Lilleri D; Fornara C; Furione M; Zavattoni M; Revello MG; Gerna G
J Infect Dis; 2007 Apr; 195(7):1062-70. PubMed ID: 17330798
[TBL] [Abstract][Full Text] [Related]
40. Multimer staining of cytomegalovirus phosphoprotein 65-specific T cells for diagnosis and therapeutic purposes: a comparative study.
Yao J; Bechter C; Wiesneth M; Härter G; Götz M; Germeroth L; Guillaume P; Hasan F; von Harsdorf S; Mertens T; Michel D; Döhner H; Bunjes D; Schmitt M; Schmitt A
Clin Infect Dis; 2008 May; 46(10):e96-105. PubMed ID: 18419478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]